(2-(Ethoxycarbonyl)furan-3-yl)boronic acid, 95.0%, 500mg

2-Bromo-6-cyanopyrazine, 95.0%, 250mg

GC capillary column ROTI®Cap-5, 30 m, 0.25 mm, 0.10 µm, 1 Piece(s)

3-Phenoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95.0%, 5g

2',4'-Difluoro-3-(4-fluorophenyl)propiophenone, 97.0%, 1g

Sodium ((4-aminophenyl)sulfonyl)(6-methoxypyrimidin-4-yl)amide, 97.0%, 100g

Ethyl 4-bromothiophene-3-carboxylate, 97%, 5g

1-(5-Bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)-2,2,2-trichloroethanone, 98%, 1g

(3R)-3-AMINO-3-(2,3-DIFLUOROPHENYL)PROPANOIC ACID, 95%, 100mg

Piperazine, 1-[2-(3,4-dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)-, hydrochloride (1:2), 98%, 10mg

Fmoc-Lys(Me)3-OH Cl, 95.0%, 10g

1-Cyclohexeneacetonitrile, 92.0%, 25g

2-BROMO-4-FLUORO-5-METHOXYBENZOIC ACID, 95.0%, 25g